Abstract
Acute renal failure (ARF) is both common and associated with significant mortality in the intensive care unit (ICU) setting (1). With an impact on length of stay, likelihood of survival until discharge, and cost of care, it is vital that the increasing body of evidence in critical care nephrology is used to refine definitions, diagnosis, preventive strategies, investigations, and management of these patients (2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA. 1996;275(19):1489–1494.
Kellum JA. Acute renal failure, interdisciplinary knowledge and the need for standardization. Curr Opin Crit Care. 2005;11(6):525–526.
Liano G, Pascual J. Acute renal failure. Madrid Acute Renal Failure Study Group. Lancet. 1996;347(8999):479.
Herget-Rosenthal S, Marggraf G, Husing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004;66(3):1115–1122.
Madaio MP. Renal biopsy. Kidney Int. 1990;38(3):529–543.
Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002;162(3):329–336.
Kellum JA, Leblanc M, Gibney RT, et al. Primary prevention of acute renal failure in the critically ill. Curr Opin Crit Care. 2005;11(6):537–541.
Rahman SN, Conger JD. Glomerular and tubular factors in urine flow rates of acute renal failure patients. Am J Kidney Dis. 1994;23(6):788–793.
Lassnigg A, Donner E, Grubhofer G, et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000; 11(1): 97–104.
Allgren RL, Marbury TC, Rahman SN, et al. Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med. 1997;336(12):828–834.
Cantarovich F, Rangoonwala B, Lorenz H, et al. High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebocontrolled, multicenter trial. Am J Kidney Dis. 2004;44(3):402–409.
Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331(21):1416–420.
Kellum JA. Diuretics in acute renal failure: protective or deleterious. Blood Purif. 1997;15(4–6):319–322.
Kellum JA. The use of diuretics and dopamine in acute renal failure: a systematic review of the evidence. Crit Care (Lond). 1997;1(2):53–59.
Homsi E, Barreiro MF, Orlando JM, Higa EM. Prophylaxis of acute renal failure in patients with rhabdomyolysis. Ren Fail. 1997;19(2):283–288.
Ip-Yam PC, Murphy S, Baines M, et al. Renal function and proteinuria after cardiopulmonary bypass: the effects of temperature and mannitol. Anesth Analg. 1994;78(5):842–847.
Gubern JM, Sancho JJ, Simo J, Sitges-Serra A. A randomized trial on the effect of mannitol on postoperative renal function in patients with obstructive jaundice. Surgery. 1988;103(1):39–44.
Denton MD, Chertow GM, Brady HR. “Renal-dose” dopamine for the treatment of acute renal failure: scientific rationale, experimental studies and clinical trials. Kidney Int. 1996;50(1):4–14.
Baldwin L, Henderson A, Hickman P. Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med. 1994;120(9):744–747.
Marik PE, Iglesias J. Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria. NORASEPT II Study Investigators. Am J Med. 1999;107(4):387–390.
Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000;356(9248):2139–2143.
Tumlin JA, Finkel KW, Murray PT, et al. Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis. 2005;46(1):26–34.
Birck R, Krzossok S, Markowetz F, et al. Acetylcysteine for prevention of contrast nephropathy: metaanalysis. Lancet. 2003;362(9384):598–603.
Pannu N, Manns B, Lee H, Tonelli M. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int. 2004;65(4):1366–1374.
Genet S, Kale RK, Baquer NZ. Effects of free radicals on cytosolic creatine kinase activities and protection by antioxidant enzymes and sulfhydryl compounds. Mol Cell Biochem. 2000;210(1–2):23–28.
Bagshaw SM, McAlister FA, Manns BJ, Ghali WA. Acetyl-cysteine used in the prevention of contrast-induced nephropathy: a case study in the pitfalls in the evolution of evidence. Arch Intern Med. 2006 Jan 23;166(2):161–166.
Lewis J, Salem MM, Chertow GM, et al. Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis. 2000;36(4):767–774.
Kramer BK, Preuner J, Ebenburger A, et al. Lack of renoprotective effect of theophylline during aortocoronary bypass surgery. Nephrol Dial Transplant. 2002;17(5):910–915.
Levy B, Bollaert PE, Charpentier C, et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med. 1997;23(3):282–287.
Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359.
Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med. 2003;31(2):359–366.
Doig GS, Simpson F. Evidence-based guidelines for nutritional support of the critically ill: results of a bi-national guideline development conference. Sydney: EvidenceBased.net; 2005. Download www. EvidenceBased.net.
Dhaliwal R, Heyland DK. Nutrition and infection in the intensive care unit: what does the evidence show? Curr Opin Crit Care. 2005;11(5):461–467.
Doig GS, Simpson F. Early enteral nutrition in the critically ill: do we need more evidence or better evidence? Curr Opin Crit Care. 2006;12(2):126–130.
Bellomo R, Goldsmith D, Uchino S, Buckmaster J, Hart G, Opdam H, Silvester W, Doolan L, Gutteridge G. Prospective controlled trial on the effect of medical emergency team on postoperative morbidity and mortality rates. Crit Care Med. 2004;32(4):916–921.
Hillman K, Chen J, Cretikos M, Bellomo R, Brown D, Doig G, Finfer S, Flabouris A; MERIT study investigators. Introduction of the medical emergency team (MET) system: a cluster-randomised controlled trial. Lancet. 2005;365(9477):2091–2097.
Bellomo R, Bonventre J, Macias W, Pinsky M. Management of early acute renal failure: focus on postinjury prevention. Curr Opin Crit Care. 2005;11(6):542–547.
Vincent JL, Weil MH. Fluid challenge revisited. Crit Care Med. 2006;34(5):1333–1337.
Kohli HS, Bhaskaran MC, Muthukumar T, et al. Treatment-related acute renal failure in the elderly: a hospital-based prospective study. Nephrol Dial Transplant. 2000;15(2):212–217.
Suen WS, Mok CK, Chiu SW, et al. Risk factors for development of acute renal failure (ARF) requiring dialysis in patients undergoing cardiac surgery. Angiology. 1998;49(10):789–800.
Uchino S, Bellomo R, Morimatsu H, et al. External validation of severity scoring systems for acute renal failure using a multinational database. Crit Care Med. 2005;33(9):1961–1967.
Murray PT, Le Gall JR, Dos Reis Miranda D, et al. Physiologic endpoints (efficacy) for acute renal failure studies. Curr Opin Crit Care. 2002;8(6):519–525.
Nash K, et al. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39(5):930–936.
Parfrey P, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med. 1989;320(3):143–149.
Brun-Buisson C, et al. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med. 2004;30(4):580–588.
Ricci Z, et al. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol Dial Transplant. 2006;21(3):690–696.
Han MK, Hyzy R. Advances in critical care management of hepatic failure and insufficiency. Crit Care Med. 2006;34(9 Suppl):S225–231.
Barrett B, et al. Meta analysis of the relative nephrotoxicity of high-and low-osmolality iodinated contrast media. Radiology. 1993;188(1):171–178.
Aspelin P, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348(6):491–499.
McCullogh PA, et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol. 2006;98(68):27K–36K.
Mangano C, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med. 1998;128(3):194–203.
Chertow G, et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104(4):343–348.
Lima E, et al. Risk factors for development of acute renal failure after liver transplantation. Ren Fail. 2003;25(4):553–560.
McNelis J, et al. Abdominal compartment syndrome: clinical manifestations and predictive factors. Curr Opin Crit Care. 2003;9(2):133–136.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag London Limited
About this chapter
Cite this chapter
Harley, N. (2008). Medical Management of Acute Renal Failure. In: Blakeley, S. (eds) Renal Failure and Replacement Therapies. Competency-Based Critical Care. Springer, London. https://doi.org/10.1007/978-1-84628-937-8_5
Download citation
DOI: https://doi.org/10.1007/978-1-84628-937-8_5
Publisher Name: Springer, London
Print ISBN: 978-1-84628-936-1
Online ISBN: 978-1-84628-937-8
eBook Packages: MedicineMedicine (R0)